Structure

Physi-Chem Properties

Molecular Weight:  340.13
Volume:  345.746
LogP:  3.458
LogD:  2.84
LogS:  -4.501
# Rotatable Bonds:  2
TPSA:  75.99
# H-Bond Aceptor:  5
# H-Bond Donor:  2
# Rings:  4
# Heavy Atoms:  5

MedChem Properties

QED Drug-Likeness Score:  0.878
Synthetic Accessibility Score:  3.512
Fsp3:  0.35
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  1
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.598
MDCK Permeability:  3.810259295278229e-05
Pgp-inhibitor:  0.856
Pgp-substrate:  0.002
Human Intestinal Absorption (HIA):  0.005
20% Bioavailability (F20%):  0.001
30% Bioavailability (F30%):  0.082

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.122
Plasma Protein Binding (PPB):  89.33834838867188%
Volume Distribution (VD):  0.343
Pgp-substrate:  4.835639953613281%

ADMET: Metabolism

CYP1A2-inhibitor:  0.195
CYP1A2-substrate:  0.103
CYP2C19-inhibitor:  0.831
CYP2C19-substrate:  0.222
CYP2C9-inhibitor:  0.813
CYP2C9-substrate:  0.907
CYP2D6-inhibitor:  0.723
CYP2D6-substrate:  0.802
CYP3A4-inhibitor:  0.19
CYP3A4-substrate:  0.315

ADMET: Excretion

Clearance (CL):  13.702
Half-life (T1/2):  0.378

ADMET: Toxicity

hERG Blockers:  0.034
Human Hepatotoxicity (H-HT):  0.582
Drug-inuced Liver Injury (DILI):  0.79
AMES Toxicity:  0.167
Rat Oral Acute Toxicity:  0.548
Maximum Recommended Daily Dose:  0.856
Skin Sensitization:  0.078
Carcinogencity:  0.832
Eye Corrosion:  0.004
Eye Irritation:  0.3
Respiratory Toxicity:  0.731

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC472580

Natural Product ID:  NPC472580
Common Name*:   LUAITIFQFJTQKA-LPHOPBHVSA-N
IUPAC Name:   n.a.
Synonyms:  
Standard InCHIKey:  LUAITIFQFJTQKA-LPHOPBHVSA-N
Standard InCHI:  InChI=1S/C20H20O5/c1-20(2,23)19-8-12-7-14-15(22)9-16(11-3-5-13(21)6-4-11)24-18(14)10-17(12)25-19/h3-7,10,16,19,21,23H,8-9H2,1-2H3/t16-,19-/m0/s1
SMILES:  Oc1ccc(cc1)[C@@H]1CC(=O)c2c(O1)cc1c(c2)C[C@H](O1)C(O)(C)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL3577242
PubChem CID:   n.a.
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000334] Flavonoids
        • [CHEMONTID:0000337] Flavans
          • [CHEMONTID:0003646] 6-prenylated flavans
            • [CHEMONTID:0003507] 6-prenylated flavanones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO30150 Psoralea corylifolia Species Fabaceae Eukaryota seeds n.a. n.a. PMID[18359631]
NPO30150 Psoralea corylifolia Species Fabaceae Eukaryota Fruits n.a. n.a. PMID[25710081]
NPO30150 Psoralea corylifolia Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[3069958]
NPO30150 Psoralea corylifolia Species Fabaceae Eukaryota n.a. seed n.a. PMID[8759164]
NPO30150 Psoralea corylifolia Species Fabaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO30150 Psoralea corylifolia Species Fabaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT81 Cell Line A549 Homo sapiens IC50 > 10000.0 nM PMID[488726]
NPT111 Cell Line K562 Homo sapiens IC50 > 10000.0 nM PMID[488726]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC472580 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9931 High Similarity NPC477957
0.9931 High Similarity NPC473996
0.9862 High Similarity NPC472636
0.9795 High Similarity NPC31627
0.9795 High Similarity NPC476238
0.9795 High Similarity NPC327269
0.9795 High Similarity NPC285623
0.9793 High Similarity NPC472421
0.9726 High Similarity NPC263384
0.9726 High Similarity NPC472423
0.9726 High Similarity NPC472422
0.9726 High Similarity NPC472420
0.9726 High Similarity NPC474744
0.9726 High Similarity NPC471676
0.9726 High Similarity NPC471675
0.9726 High Similarity NPC244577
0.9726 High Similarity NPC474772
0.9595 High Similarity NPC223701
0.9595 High Similarity NPC472583
0.9595 High Similarity NPC7989
0.9592 High Similarity NPC471677
0.9589 High Similarity NPC472628
0.9586 High Similarity NPC14875
0.9586 High Similarity NPC472627
0.9583 High Similarity NPC209040
0.953 High Similarity NPC477958
0.9527 High Similarity NPC35567
0.9527 High Similarity NPC475790
0.9527 High Similarity NPC243171
0.9527 High Similarity NPC171651
0.9521 High Similarity NPC168085
0.9514 High Similarity NPC106985
0.9514 High Similarity NPC478086
0.9514 High Similarity NPC175504
0.9514 High Similarity NPC257097
0.9514 High Similarity NPC221432
0.9514 High Similarity NPC166138
0.9514 High Similarity NPC150408
0.9514 High Similarity NPC310130
0.9514 High Similarity NPC164980
0.9514 High Similarity NPC39329
0.9514 High Similarity NPC316816
0.9514 High Similarity NPC75049
0.9514 High Similarity NPC18585
0.9514 High Similarity NPC91560
0.9514 High Similarity NPC149026
0.9514 High Similarity NPC143896
0.9514 High Similarity NPC214166
0.9514 High Similarity NPC169591
0.9514 High Similarity NPC68104
0.9463 High Similarity NPC293286
0.9463 High Similarity NPC469405
0.9459 High Similarity NPC262038
0.9459 High Similarity NPC254412
0.9459 High Similarity NPC262039
0.9459 High Similarity NPC278476
0.9459 High Similarity NPC319910
0.9459 High Similarity NPC474021
0.9459 High Similarity NPC474023
0.9456 High Similarity NPC89442
0.9456 High Similarity NPC317492
0.9452 High Similarity NPC473077
0.9452 High Similarity NPC296998
0.9452 High Similarity NPC23728
0.9452 High Similarity NPC110303
0.9448 High Similarity NPC197252
0.9448 High Similarity NPC236766
0.9448 High Similarity NPC131568
0.9448 High Similarity NPC473013
0.9448 High Similarity NPC131579
0.9448 High Similarity NPC473015
0.9444 High Similarity NPC66515
0.9444 High Similarity NPC306829
0.9444 High Similarity NPC32739
0.9444 High Similarity NPC147145
0.9444 High Similarity NPC107572
0.9444 High Similarity NPC324134
0.9444 High Similarity NPC296917
0.9444 High Similarity NPC166934
0.9444 High Similarity NPC324436
0.9444 High Similarity NPC194432
0.9444 High Similarity NPC161506
0.9444 High Similarity NPC37496
0.9444 High Similarity NPC167624
0.9444 High Similarity NPC40833
0.9444 High Similarity NPC227579
0.9444 High Similarity NPC228504
0.9444 High Similarity NPC220998
0.9444 High Similarity NPC76338
0.9444 High Similarity NPC78
0.9444 High Similarity NPC166482
0.9444 High Similarity NPC223500
0.9444 High Similarity NPC64915
0.9444 High Similarity NPC177354
0.9444 High Similarity NPC10937
0.9444 High Similarity NPC265040
0.9444 High Similarity NPC328164
0.9444 High Similarity NPC182852
0.9444 High Similarity NPC76372
0.9444 High Similarity NPC144499
0.9444 High Similarity NPC1089
0.9444 High Similarity NPC125855
0.9444 High Similarity NPC148757
0.9408 High Similarity NPC472624
0.9408 High Similarity NPC328102
0.94 High Similarity NPC279218
0.94 High Similarity NPC304207
0.94 High Similarity NPC48579
0.94 High Similarity NPC207809
0.94 High Similarity NPC108937
0.94 High Similarity NPC217706
0.94 High Similarity NPC470681
0.94 High Similarity NPC259710
0.9396 High Similarity NPC138288
0.9396 High Similarity NPC56232
0.9396 High Similarity NPC161881
0.9396 High Similarity NPC210597
0.9396 High Similarity NPC10807
0.9396 High Similarity NPC150123
0.9396 High Similarity NPC244583
0.9396 High Similarity NPC216035
0.9396 High Similarity NPC217149
0.9392 High Similarity NPC105136
0.9388 High Similarity NPC160821
0.9388 High Similarity NPC132592
0.9384 High Similarity NPC83357
0.9384 High Similarity NPC67805
0.9384 High Similarity NPC312973
0.9384 High Similarity NPC176229
0.9384 High Similarity NPC316769
0.9384 High Similarity NPC20488
0.9384 High Similarity NPC472629
0.9384 High Similarity NPC214774
0.9384 High Similarity NPC285630
0.9384 High Similarity NPC142405
0.9384 High Similarity NPC267375
0.9384 High Similarity NPC475052
0.9384 High Similarity NPC88964
0.9384 High Similarity NPC470647
0.9384 High Similarity NPC127059
0.9384 High Similarity NPC246948
0.9384 High Similarity NPC301276
0.9384 High Similarity NPC54577
0.9384 High Similarity NPC195621
0.9384 High Similarity NPC477955
0.9384 High Similarity NPC111786
0.9379 High Similarity NPC85162
0.9379 High Similarity NPC81697
0.9379 High Similarity NPC185276
0.9379 High Similarity NPC125894
0.9379 High Similarity NPC278249
0.9379 High Similarity NPC107177
0.9379 High Similarity NPC223812
0.9379 High Similarity NPC77794
0.9375 High Similarity NPC96408
0.9375 High Similarity NPC4743
0.9375 High Similarity NPC213322
0.9375 High Similarity NPC258630
0.9375 High Similarity NPC17170
0.9375 High Similarity NPC156190
0.9375 High Similarity NPC171870
0.9375 High Similarity NPC279650
0.9375 High Similarity NPC248372
0.9375 High Similarity NPC312391
0.9375 High Similarity NPC110038
0.9375 High Similarity NPC166689
0.9375 High Similarity NPC3188
0.9375 High Similarity NPC324386
0.9351 High Similarity NPC472581
0.9351 High Similarity NPC124038
0.9346 High Similarity NPC45124
0.9346 High Similarity NPC30655
0.9346 High Similarity NPC74854
0.9346 High Similarity NPC92589
0.9338 High Similarity NPC10754
0.9338 High Similarity NPC321372
0.9338 High Similarity NPC208152
0.9338 High Similarity NPC474609
0.9338 High Similarity NPC78554
0.9338 High Similarity NPC109967
0.9338 High Similarity NPC78492
0.9338 High Similarity NPC129053
0.9338 High Similarity NPC20530
0.9338 High Similarity NPC474738
0.9338 High Similarity NPC469936
0.9338 High Similarity NPC215917
0.9338 High Similarity NPC475797
0.9333 High Similarity NPC122365
0.9333 High Similarity NPC236756
0.9333 High Similarity NPC100134
0.9333 High Similarity NPC311579
0.9333 High Similarity NPC248793
0.9333 High Similarity NPC209760
0.9333 High Similarity NPC180301
0.9329 High Similarity NPC289774
0.9329 High Similarity NPC477897
0.9329 High Similarity NPC328740
0.9329 High Similarity NPC209846
0.9329 High Similarity NPC471229
0.9324 High Similarity NPC473016

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC472580 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9276 High Similarity NPD7075 Discontinued
0.9262 High Similarity NPD4380 Phase 2
0.9205 High Similarity NPD7096 Clinical (unspecified phase)
0.9205 High Similarity NPD2393 Clinical (unspecified phase)
0.9167 High Similarity NPD1549 Phase 2
0.9097 High Similarity NPD1552 Clinical (unspecified phase)
0.9097 High Similarity NPD1550 Clinical (unspecified phase)
0.9054 High Similarity NPD4378 Clinical (unspecified phase)
0.9013 High Similarity NPD1934 Approved
0.8926 High Similarity NPD7410 Clinical (unspecified phase)
0.8903 High Similarity NPD4381 Clinical (unspecified phase)
0.8897 High Similarity NPD2796 Approved
0.8896 High Similarity NPD8443 Clinical (unspecified phase)
0.8889 High Similarity NPD6801 Discontinued
0.8839 High Similarity NPD3882 Suspended
0.8828 High Similarity NPD1510 Phase 2
0.8824 High Similarity NPD7411 Suspended
0.8733 High Similarity NPD6799 Approved
0.871 High Similarity NPD7819 Suspended
0.8681 High Similarity NPD1240 Approved
0.8671 High Similarity NPD5494 Approved
0.8642 High Similarity NPD7804 Clinical (unspecified phase)
0.8598 High Similarity NPD6559 Discontinued
0.859 High Similarity NPD2801 Approved
0.858 High Similarity NPD3818 Discontinued
0.8571 High Similarity NPD6167 Clinical (unspecified phase)
0.8571 High Similarity NPD6166 Phase 2
0.8571 High Similarity NPD6168 Clinical (unspecified phase)
0.8562 High Similarity NPD1607 Approved
0.8516 High Similarity NPD6599 Discontinued
0.8487 Intermediate Similarity NPD1511 Approved
0.8457 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.8428 Intermediate Similarity NPD3749 Approved
0.8385 Intermediate Similarity NPD6959 Discontinued
0.8377 Intermediate Similarity NPD1512 Approved
0.8365 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8365 Intermediate Similarity NPD7768 Phase 2
0.8364 Intermediate Similarity NPD7074 Phase 3
0.8344 Intermediate Similarity NPD2800 Approved
0.8344 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.8323 Intermediate Similarity NPD5403 Approved
0.8303 Intermediate Similarity NPD7054 Approved
0.8302 Intermediate Similarity NPD3817 Phase 2
0.8253 Intermediate Similarity NPD7472 Approved
0.8224 Intermediate Similarity NPD1243 Approved
0.8205 Intermediate Similarity NPD920 Approved
0.8204 Intermediate Similarity NPD6797 Phase 2
0.8194 Intermediate Similarity NPD5401 Approved
0.8182 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.817 Intermediate Similarity NPD4628 Phase 3
0.817 Intermediate Similarity NPD3750 Approved
0.8155 Intermediate Similarity NPD7251 Discontinued
0.8146 Intermediate Similarity NPD1551 Phase 2
0.8107 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.8107 Intermediate Similarity NPD7808 Phase 3
0.8092 Intermediate Similarity NPD2344 Approved
0.8084 Intermediate Similarity NPD5844 Phase 1
0.8077 Intermediate Similarity NPD2534 Approved
0.8077 Intermediate Similarity NPD2533 Approved
0.8077 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.8077 Intermediate Similarity NPD2532 Approved
0.8075 Intermediate Similarity NPD5402 Approved
0.8041 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.8037 Intermediate Similarity NPD919 Approved
0.8026 Intermediate Similarity NPD2935 Discontinued
0.8 Intermediate Similarity NPD6232 Discontinued
0.8 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7988 Intermediate Similarity NPD5953 Discontinued
0.7964 Intermediate Similarity NPD7473 Discontinued
0.7961 Intermediate Similarity NPD2799 Discontinued
0.7947 Intermediate Similarity NPD6651 Approved
0.7939 Intermediate Similarity NPD1247 Approved
0.7922 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7919 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7917 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7885 Intermediate Similarity NPD2309 Approved
0.7882 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.787 Intermediate Similarity NPD7286 Phase 2
0.7844 Intermediate Similarity NPD3926 Phase 2
0.7843 Intermediate Similarity NPD3748 Approved
0.7843 Intermediate Similarity NPD7033 Discontinued
0.7821 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7815 Intermediate Similarity NPD943 Approved
0.78 Intermediate Similarity NPD2313 Discontinued
0.7792 Intermediate Similarity NPD6100 Approved
0.7792 Intermediate Similarity NPD6099 Approved
0.7785 Intermediate Similarity NPD4908 Phase 1
0.7765 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.775 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.774 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7727 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7707 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7703 Intermediate Similarity NPD1203 Approved
0.7697 Intermediate Similarity NPD1613 Approved
0.7697 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7692 Intermediate Similarity NPD2424 Discontinued
0.7683 Intermediate Similarity NPD1465 Phase 2
0.7676 Intermediate Similarity NPD7584 Approved
0.7671 Intermediate Similarity NPD1610 Phase 2
0.7667 Intermediate Similarity NPD6832 Phase 2
0.7654 Intermediate Similarity NPD4363 Phase 3
0.7654 Intermediate Similarity NPD4360 Phase 2
0.7654 Intermediate Similarity NPD3226 Approved
0.7647 Intermediate Similarity NPD5124 Phase 1
0.7647 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7628 Intermediate Similarity NPD2346 Discontinued
0.7616 Intermediate Similarity NPD1729 Discontinued
0.7614 Intermediate Similarity NPD8434 Phase 2
0.7611 Intermediate Similarity NPD4361 Phase 2
0.7611 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.7602 Intermediate Similarity NPD3751 Discontinued
0.7574 Intermediate Similarity NPD5710 Approved
0.7574 Intermediate Similarity NPD5711 Approved
0.7566 Intermediate Similarity NPD6798 Discontinued
0.7561 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.755 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7546 Intermediate Similarity NPD7458 Discontinued
0.7543 Intermediate Similarity NPD8313 Approved
0.7543 Intermediate Similarity NPD8312 Approved
0.7541 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7533 Intermediate Similarity NPD2798 Approved
0.7532 Intermediate Similarity NPD2654 Approved
0.7532 Intermediate Similarity NPD1933 Approved
0.7532 Intermediate Similarity NPD6355 Discontinued
0.7517 Intermediate Similarity NPD1548 Phase 1
0.7516 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7515 Intermediate Similarity NPD7199 Phase 2
0.75 Intermediate Similarity NPD4625 Phase 3
0.75 Intermediate Similarity NPD9717 Approved
0.75 Intermediate Similarity NPD4308 Phase 3
0.7483 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7471 Intermediate Similarity NPD3823 Discontinued
0.7471 Intermediate Similarity NPD3787 Discontinued
0.7458 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7453 Intermediate Similarity NPD7390 Discontinued
0.7453 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7451 Intermediate Similarity NPD3268 Approved
0.7451 Intermediate Similarity NPD3764 Approved
0.7446 Intermediate Similarity NPD6780 Approved
0.7446 Intermediate Similarity NPD6778 Approved
0.7446 Intermediate Similarity NPD6782 Approved
0.7446 Intermediate Similarity NPD6781 Approved
0.7446 Intermediate Similarity NPD6776 Approved
0.7446 Intermediate Similarity NPD6777 Approved
0.7446 Intermediate Similarity NPD6779 Approved
0.7439 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.743 Intermediate Similarity NPD4287 Approved
0.7427 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7419 Intermediate Similarity NPD230 Phase 1
0.7407 Intermediate Similarity NPD4662 Approved
0.7407 Intermediate Similarity NPD4661 Approved
0.7405 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7399 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.7396 Intermediate Similarity NPD6234 Discontinued
0.7386 Intermediate Similarity NPD3027 Phase 3
0.7384 Intermediate Similarity NPD2403 Approved
0.7368 Intermediate Similarity NPD7229 Phase 3
0.7365 Intermediate Similarity NPD8455 Phase 2
0.7365 Intermediate Similarity NPD5760 Phase 2
0.7365 Intermediate Similarity NPD5761 Phase 2
0.7362 Intermediate Similarity NPD5049 Phase 3
0.7351 Intermediate Similarity NPD2797 Approved
0.7333 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7329 Intermediate Similarity NPD3887 Approved
0.7329 Intermediate Similarity NPD2354 Approved
0.7326 Intermediate Similarity NPD7435 Discontinued
0.7321 Intermediate Similarity NPD2296 Approved
0.7318 Intermediate Similarity NPD8150 Discontinued
0.7315 Intermediate Similarity NPD422 Phase 1
0.7312 Intermediate Similarity NPD1652 Phase 2
0.7308 Intermediate Similarity NPD447 Suspended
0.7308 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7305 Intermediate Similarity NPD37 Approved
0.7296 Intermediate Similarity NPD1471 Phase 3
0.729 Intermediate Similarity NPD6233 Phase 2
0.7283 Intermediate Similarity NPD4575 Clinical (unspecified phase)
0.7283 Intermediate Similarity NPD7784 Clinical (unspecified phase)
0.7279 Intermediate Similarity NPD9545 Approved
0.7278 Intermediate Similarity NPD4967 Phase 2
0.7278 Intermediate Similarity NPD4965 Approved
0.7278 Intermediate Similarity NPD4966 Approved
0.7267 Intermediate Similarity NPD3972 Approved
0.7263 Intermediate Similarity NPD7585 Approved
0.7255 Intermediate Similarity NPD2861 Phase 2
0.7246 Intermediate Similarity NPD5890 Approved
0.7246 Intermediate Similarity NPD5889 Approved
0.7244 Intermediate Similarity NPD4307 Phase 2
0.7244 Intermediate Similarity NPD4060 Phase 1
0.7234 Intermediate Similarity NPD7697 Approved
0.7234 Intermediate Similarity NPD7698 Approved
0.7234 Intermediate Similarity NPD7696 Phase 3
0.7232 Intermediate Similarity NPD6104 Discontinued
0.7226 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7225 Intermediate Similarity NPD8151 Discontinued
0.7222 Intermediate Similarity NPD6190 Approved
0.7219 Intermediate Similarity NPD4749 Approved
0.7219 Intermediate Similarity NPD4288 Approved
0.7211 Intermediate Similarity NPD7583 Approved
0.7202 Intermediate Similarity NPD6280 Approved
0.7202 Intermediate Similarity NPD6844 Discontinued

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data